Search research articles
Contact Us
Filters
Showing results (61-70 of 567) with videos related to
Page
of 57
Sort By:
Chinese Clinical Oncology
|
July 18, 2019
Challenges and insights of early oncology drug development in the Asia-Pacific region: introduction of phase I oncology clinical trial center and experience sharing for early clinical trials in Seoul National University Hospital, Korea
Seock-Ah Im, Dae-Won Lee, Ryungwoo Kang, et al.
Biochemical and Biophysical Research Communications
|
January 24, 2008
Class II histone deacetylases play pivotal roles in heat shock protein 90-mediated proteasomal degradation of vascular endothelial growth factor receptors
Jung-Hyun Park, Sung-Hak Kim, Moon-Chang Choi, et al.
Plos One
|
October 6, 2015
Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index
Younak Choi, Do-Youn Oh, Tae-Yong Kim, et al.
Radiology
|
May 20, 2016
Pretreatment MR Imaging Features of Triple-Negative Breast Cancer: Association with Response to Neoadjuvant Chemotherapy and Recurrence-Free Survival
Min Sun Bae, Sung Ui Shin, Han Suk Ryu, et al.
Annals of Surgical Oncology
|
March 19, 2013
Breast-conserving surgery after tumor downstaging by neoadjuvant chemotherapy is oncologically safe for stage III breast cancer patients
Hee-Chul Shin, Wonshik Han, Hyeong-Gon Moon, et al.
Journal of Pain and Symptom Management
|
December 11, 2013
The impact of body mass index dynamics on survival of patients with advanced pancreatic cancer receiving chemotherapy
Younak Choi, Tae-Yong Kim, Kyung-hun Lee, et al.
Breast Cancer Research and Treatment
|
April 26, 2008
Cost-effectiveness analysis of adjuvant therapy for node positive breast cancer in Korea: docetaxel, doxorubicin and cyclophosphamide (TAC) versus fluorouracil, doxorubicin and cyclophosphamide (FAC)
Sang Gyu Lee, Young Geon Jee, Hyun Chul Chung, et al.
Breast Cancer Research and Treatment
|
September 14, 2018
Effects of trastuzumab on locoregional recurrence in human epidermal growth factor receptor 2-overexpressing breast cancer patients treated with chemotherapy and radiotherapy
Seung Hyuck Jeon, Kyung Hwan Shin, Jin Ho Kim, et al.
Cancer Research and Treatment
|
March 18, 2015
The Impact of Diabetes Mellitus and Metformin Treatment on Survival of Patients with Advanced Pancreatic Cancer Undergoing Chemotherapy
Younak Choi, Tae-Yong Kim, Do-Youn Oh, et al.
Cancer Chemotherapy and Pharmacology
|
February 18, 2011
Efficacy of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (iFAM) in the treatment of patients with gemcitabine-pretreated pancreatic cancer and analysis of prognostic factors in a salvage setting
Kyu-Hyoung Lim, Tae-Yong Kim, Kyung-Hun Lee, et al.
Page
of 57
Search research articles
Search
Showing results (61-70 of 567) with videos related to
Sort By:
Page
of 57
Chinese Clinical Oncology
|
July 18, 2019
Challenges and insights of early oncology drug development in the Asia-Pacific region: introduction of phase I oncology clinical trial center and experience sharing for early clinical trials in Seoul National University Hospital, Korea
Seock-Ah Im, Dae-Won Lee, Ryungwoo Kang, et al.
Biochemical and Biophysical Research Communications
|
January 24, 2008
Class II histone deacetylases play pivotal roles in heat shock protein 90-mediated proteasomal degradation of vascular endothelial growth factor receptors
Jung-Hyun Park, Sung-Hak Kim, Moon-Chang Choi, et al.
Plos One
|
October 6, 2015
Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index
Younak Choi, Do-Youn Oh, Tae-Yong Kim, et al.
Radiology
|
May 20, 2016
Pretreatment MR Imaging Features of Triple-Negative Breast Cancer: Association with Response to Neoadjuvant Chemotherapy and Recurrence-Free Survival
Min Sun Bae, Sung Ui Shin, Han Suk Ryu, et al.
Annals of Surgical Oncology
|
March 19, 2013
Breast-conserving surgery after tumor downstaging by neoadjuvant chemotherapy is oncologically safe for stage III breast cancer patients
Hee-Chul Shin, Wonshik Han, Hyeong-Gon Moon, et al.
Journal of Pain and Symptom Management
|
December 11, 2013
The impact of body mass index dynamics on survival of patients with advanced pancreatic cancer receiving chemotherapy
Younak Choi, Tae-Yong Kim, Kyung-hun Lee, et al.
Breast Cancer Research and Treatment
|
April 26, 2008
Cost-effectiveness analysis of adjuvant therapy for node positive breast cancer in Korea: docetaxel, doxorubicin and cyclophosphamide (TAC) versus fluorouracil, doxorubicin and cyclophosphamide (FAC)
Sang Gyu Lee, Young Geon Jee, Hyun Chul Chung, et al.
Breast Cancer Research and Treatment
|
September 14, 2018
Effects of trastuzumab on locoregional recurrence in human epidermal growth factor receptor 2-overexpressing breast cancer patients treated with chemotherapy and radiotherapy
Seung Hyuck Jeon, Kyung Hwan Shin, Jin Ho Kim, et al.
Cancer Research and Treatment
|
March 18, 2015
The Impact of Diabetes Mellitus and Metformin Treatment on Survival of Patients with Advanced Pancreatic Cancer Undergoing Chemotherapy
Younak Choi, Tae-Yong Kim, Do-Youn Oh, et al.
Cancer Chemotherapy and Pharmacology
|
February 18, 2011
Efficacy of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (iFAM) in the treatment of patients with gemcitabine-pretreated pancreatic cancer and analysis of prognostic factors in a salvage setting
Kyu-Hyoung Lim, Tae-Yong Kim, Kyung-Hun Lee, et al.
Page
of 57